ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) shares traded up 8.1% during mid-day trading on Tuesday . The company traded as high as $2.12 and last traded at $2.00. 2,082,644 shares changed hands during mid-day trading, an increase of 10,146% from the average session volume of 20,327 shares. The stock had previously closed at $1.85.
ImmunoPrecise Antibodies Price Performance
The business has a 50-day moving average of $1.34 and a 200-day moving average of $0.75.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Recommended Stories
- Five stocks we like better than ImmunoPrecise Antibodies
- Best Energy Stocks – Energy Stocks to Buy Now
- NFL and WWE Land on ESPN—The Impact on Disney and TKO Stocks
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- If Qualcomm Holds $145, Its Next Move Could Be Massive
- What Are Dividend Challengers?
- Intel’s White House Reset: From Political Storm to a Clearer Sky
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
